|
Q2 FY2027
As of Jul 31, 2026
|
Q1 FY2027
As of Apr 30, 2026
|
Q4 FY2026
As of Jan 31, 2026
|
Q3 FY2026
As of Oct 31, 2025
|
Q2 FY2026
As of Jul 31, 2025
|
Q1 FY2026
As of Apr 30, 2025
|
Q4 FY2025
As of Jan 31, 2025
|
Q3 FY2025
As of Oct 31, 2024
|
Q2 FY2025
As of Jul 31, 2024
|
Q1 FY2025
As of Apr 30, 2024
|
Q4 FY2024
As of Jan 31, 2024
|
Q3 FY2024
As of Oct 31, 2023
|
Q2 FY2024
As of Jul 31, 2023
|
Q1 FY2024
As of Apr 30, 2023
|
Q4 FY2023
As of Jan 31, 2023
|
Q3 FY2023
As of Oct 31, 2022
|
Q2 FY2023
As of Jul 31, 2022
|
Q1 FY2023
As of Apr 30, 2022
|
Q4 FY2022
As of Jan 31, 2022
|
Q3 FY2022
As of Oct 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| CURRENT ASSETS: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable-net | ||||||||||||||||||||
| Inventory-net | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Total Current Assets | ||||||||||||||||||||
| PROPERTY & EQUIPMENT-net | ||||||||||||||||||||
| OTHER ASSETS: | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Operating lease right of use asset | ||||||||||||||||||||
| Intangible assets-net | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| LIABILITIES | ||||||||||||||||||||
| CURRENT LIABILITIES: | ||||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Operating lease liability-current portion | ||||||||||||||||||||
| Notes payable-current portion | ||||||||||||||||||||
| Total Current Liabilities | ||||||||||||||||||||
| LONG-TERM LIABILITIES: | ||||||||||||||||||||
| Note payable-net of current portion | ||||||||||||||||||||
| Note payable-related party | ||||||||||||||||||||
| Operating lease liability-net of current portion | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| STOCKHOLDERS’ EQUITY: | ||||||||||||||||||||
| Preferred stock, $.001 par value, 10,000,000 shares authorized, -3,008,643 and -3,008,643 - issued and outstanding as of July 31, 2026 and January 31, 2026, respectively | ||||||||||||||||||||
| Common stock, $.001 par value, 291,666,666 shares authorized, 12,174,883 and 12,174,883 shares issued at July 31, 2026 and January 31, 2026, respectively, 12,155,683 and 12,155,883 shares outstanding as of July 31, 2026 and January 31, 2026, respectively | ||||||||||||||||||||
| Additional paid-in-capital | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Treasury stock, 18,900 and 18,900 shares at cost, as of April 30, 2026 and January 31, 2026, respectively | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total Stockholders’ Equity | ||||||||||||||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
Loading...
